申请人:Mitsubishi Yuka Pharmaceutical Co., Ltd.
公开号:US04352928A1
公开(公告)日:1982-10-05
There are provided a novel compound, i.e., a 2-piperazino-4-substituted-5,6-alkylenepyrimidine derivative represented by the formula: ##STR1## wherein Y, Z and n are defined in the specification and claims, and a pharmaceutically acceptable acid addition salt thereof. The compounds of the present invention show, an anti-inflammatory effect, a blood sugar level lowering effect, a blood platelet aggregation suppressive effect, an anorexigenic action and a Serotonin effect.
提供了一种新型化合物,即2-哌嗪基-4-取代-5,6-亚烷基嘧啶衍生物,其化学式为:##STR1## 其中Y、Z和n在说明书和权利要求中定义,以及药用可接受的酸加成盐。本发明的化合物显示出抗炎作用、降血糖作用、抑制血小板聚集作用、食欲抑制剂作用和血清素作用。